Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus ErythematosusM. Jallouli, Lionel Galicier, Noël Zahr et al.|Arthritis & Rheumatology|2015Cited by 140
Pollutants: a candidate as a new risk factor for osteoarthritis—results from a systematic literature reviewCamille Deprouw, Karine Louati, Alice Courties et al.|RMD Open|2022Cited by 34
Hydroxychloroquine levels in patients with systemic lupus erythematosus: whole blood is preferable but serum levels also detect non-adherenceBenoı̂t Blanchet, Aurélien Delluc, Jérémie Sellam et al.|Arthritis Research & Therapy|2020Cited by 30
Recommendations from the French Societies of Rheumatology and Physical Medicine and Rehabilitation on the non-pharmacological management of knee osteoarthritisYves‐Marie Pers, Jérémie Sellam, Christelle Nguyen et al.|Annals of Physical and Rehabilitation Medicine|2024Cited by 20
B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologicsRenaud Felten, Jacques‐Eric Gottenberg, Pierre‐Marie Duret et al.|Annals of the Rheumatic Diseases|2021Cited by 20